Patents by Inventor Basant Sharma

Basant Sharma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7282480
    Abstract: The present invention is directed to sustained-release pharmaceutical formulations of therapeutic proteins containing carboxymethyl ether cellulose polymer and methods of manufacture and use thereof.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: October 16, 2007
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Basant Sharma, Renzhe Jin, Sunitha Menon-Rudolph, Wing K. Cheung, Selima Begum, Marian Kelley
  • Publication number: 20040248797
    Abstract: The present invention provides aqueous pharmaceutical formulations of erytropoietin that are free of human serum blood products, stabilized with a quantity of an amino acid and a sorbitan mono-9-octadecenoate poly(oxy-1,2-ethanediyl) derivative. The present invention also provides aqueous stable, preserved pharmaceutical formulations of erythropoietin that contain an antimicrobial quantity of cresol and a quantity of an amino acid.
    Type: Application
    Filed: February 10, 2004
    Publication date: December 9, 2004
    Applicant: Ortho McNeil Pharmaceutical, Inc.
    Inventors: Wing K. Cheung, Jaya Natarajan, Marilyn Sanders, Els Vercammen, Selima Begum, Basant Sharma
  • Patent number: 6818613
    Abstract: The present invention is directed to sustained-release pharmaceutical formulations of therapeutic proteins containing carboxymethyl ether cellulose polymer and methods of manufacture and use thereof.
    Type: Grant
    Filed: November 7, 2001
    Date of Patent: November 16, 2004
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Basant Sharma, Renzhe Jin, Sunitha Rudolph, Wing K. Cheung, Selima Begum, Marian Kelley
  • Patent number: 6696056
    Abstract: The present invention provides aqueous pharmaceutical formulations of erythropoietin that are free of human serum blood products, stabilized with a quantity of an amino acid and a sorbitan mono-9-octadecenoate poly(oxy-1,2-ethanediyl) derivative. The present invention also provides aqueous stable, preserved pharmaceutical formulations of erythropoietin that contain an antimicrobial quantity of cresol and a quantity of an amino acid.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: February 24, 2004
    Assignee: Ortho McNeil Pharmaceutical, Inc.
    Inventors: Wing K. Cheung, Jaya Natarajan, Marilyn Sanders, Els Vercammen, Selima Begum, Basant Sharma
  • Publication number: 20030181361
    Abstract: The present invention is directed to sustained-release pharmaceutical formulations of therapeutic proteins containing carboxymethyl ether cellulose polymer and methods of manufacture and use thereof.
    Type: Application
    Filed: March 31, 2003
    Publication date: September 25, 2003
    Inventors: Basant Sharma, Renzhe Jin, Sunitha Rudolph, Wing K. Cheung, Selima Begum, Marian Kelley
  • Publication number: 20030148938
    Abstract: The present invention is directed to sustained-release pharmaceutical formulations of therapeutic proteins containing carboxymethyl ether cellulose polymer and methods of manufacture and use thereof.
    Type: Application
    Filed: November 7, 2001
    Publication date: August 7, 2003
    Inventors: Basant Sharma, Renzhe Jin, Sunitha Rudolph, Wing K. Cheung, Selima Begum, Marian Kelley